The Association Between Sarcopenia and Cognitive Performance : Data from the National Health and Nutrition Examination Surveys 1999 to 2002

Jiwen Geng,Liangliang Deng,Shi Qiu,Haiyang Bian,Boyu Cai,Yupei Li,Jiameng Li,Qin Zheng,Qinbo Yang,Birong Dong,Baihai Su

DOI: https://doi.org/10.21203/rs.3.rs-46878/v1

2020-01-01

Abstract:Background: Sarcopenia and cognitive impairment are both age-related diseases. And they have many risk factors in common. However, the association between them has been controversial in recent years. Objective: To investigate the association between sarcopenia and cognitive performance in the U.S. adults through the use of the NHANES data from 1999 to 2002. Methods: A total of 2550 participants were identified in the National Health and Nutrition Examination Surveys Data Base (1999–2002). The independent variable was sarcopenia and the dependent variables was cognitive performance. Men were classified as sarcopenia if appendicular lean mass (ALM) adjusted for BMI (ALM BMI ) <0.789, and women<0.512. The cognitive performance was assessed by Digit Symbol Substitution Test (DSST). Higher scores on the DSST indicated better cognitive performance. The covariates included gender, age, race, poverty income ratio, comorbidity index, educational level, physical activity and smoking status. Results: For the primary outcome, our multivariate linear regression analysis indicated that sarcopenia negatively correlated with cognitive performance in the model I (crude OR = 5.18; 95% CI: [3.49–6.87]). The negative association remained significant in the adjusted model II and model III (OR=3.40; 95% CI: [1.91–4.90]; OR=1.50; 95% CI: [0.12–2.89]). The subgroup analysis results indicated that participants without sarcopenia were associated with better cognitive performance was similar in different gender, age, race, poverty income ratio, comorbidity index, educational level, physical activity and smoking status. Conclusions: Participants without sarcopenia were associated with better cognitive performance in a representative sample of older adults in the U.S. We might be able to try to improve cognitive performance by dealing with sarcopenia and provide opportunity for intervention at a younger age and better physical performance.